Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
Breaking newsCOVID-19
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species -
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
-
Breaking newsCOVID-19Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals -
Breaking newsCOVID-19
Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection
Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection -
Breaking newsCOVID-19
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection -
Breaking newsCOVID-19The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis -
Breaking newsCOVID-19
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis -
Breaking newsCOVID-19
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum -
Breaking newsCOVID-19Increased transmissibility and global spread of SARSCoV-2 variants of concern as at June 2021
Increased transmissibility and global spread of SARSCoV-2 variants of concern as at June 2021 -
Two reports on Clinical Fellowships that took place in 2020 -
Breaking newsCOVID-19
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study -
Immunological imprinting of the antibody response in COVID-19 patients
-
Breaking newsCOVID-19
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies -
Dysregulation of brain and choroid plexus cell types in severe COVID-19